How The MHRA Is Ready For No-Deal Brexit Impact But Can’t Influence Other Authorities
In terms of a no-deal Brexit, the UK MHRA had drawn up its plans for medtech several months ago and is sticking by them. But even though manufacturers seemingly have more time to prepare for the delayed Brexit deadline, they should not underestimate the volume of work ahead.
You may also be interested in...
In responding to industry’s plea for more time to comply with the EU’s MDR, the European Commission’s proposed one-year delay may also create some unwelcome repercussions for manufacturers and notified bodies.
With hospitals throughout the EU short of urgently needed COVID-19 medical supplies, including respiratory equipment, there are ways for companies to sell and deliver their products quickly.
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.